| Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH T Hendrikx, F Porsch, MG Kiss, D Rajcic, N Papac-Miličević, C Hoebinger, ... Journal of hepatology 77 (5), 1373-1385, 2022 | 117 | 2022 |
| Humoral immunity in atherosclerosis and myocardial infarction: from B cells to antibodies F Porsch, Z Mallat, CJ Binder Cardiovascular research 117 (13), 2544-2562, 2021 | 66 | 2021 |
| B cell–activating factor neutralization aggravates atherosclerosis D Tsiantoulas, AP Sage, L Göderle, M Ozsvar-Kozma, D Murphy, ... Circulation 138 (20), 2263-2273, 2018 | 66 | 2018 |
| APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans D Tsiantoulas, M Eslami, G Obermayer, M Clement, D Smeets, FJ Mayer, ... Nature 597 (7874), 92-96, 2021 | 57 | 2021 |
| Impact of B-cell–targeted therapies on cardiovascular disease F Porsch, CJ Binder Arteriosclerosis, thrombosis, and vascular biology 39 (9), 1705-1714, 2019 | 34 | 2019 |
| Inadequate fine-tuning of protein synthesis and failure of amino acid homeostasis following inhibition of the ATPase VCP/p97 K Parzych, TM Chinn, Z Chen, S Loaiza, F Porsch, GN Valbuena, ... Cell death & disease 6 (12), e2031-e2031, 2015 | 34 | 2015 |
| Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis MG Kiss, N Papac-Miličević, F Porsch, D Tsiantoulas, T Hendrikx, ... Immunity 56 (8), 1809-1824. e10, 2023 | 27 | 2023 |
| TREM2 protects from atherosclerosis by limiting necrotic core formation M Piollet, F Porsch, G Rizzo, F Kapser, DJJ Schulz, MG Kiss, ... Nature cardiovascular research 3 (3), 269-282, 2024 | 22 | 2024 |
| Autoimmune diseases and atherosclerotic cardiovascular disease F Porsch, CJ Binder Nature Reviews Cardiology 21 (11), 780-807, 2024 | 19 | 2024 |
| Complement factor H modulates splenic B cell development and limits autoantibody production MG Kiss, M Ozsvár-Kozma, F Porsch, L Göderle, N Papac-Miličević, ... Frontiers in Immunology 10, 1607, 2019 | 17 | 2019 |
| Advancements in risk stratification and management strategies in primary cardiovascular prevention F Barkas, YZ Sener, PA Golforoush, A Kheirkhah, E Rodriguez-Sanchez, ... Atherosclerosis 395, 117579, 2024 | 14 | 2024 |
| Anti-inflammatory and immunomodulatory therapies in atherosclerosis J Deroissart, F Porsch, T Koller, CJ Binder Prevention and Treatment of Atherosclerosis 270, 359-404, 2021 | 12 | 2021 |
| TREM2 limits necrotic core formation during atherogenesis by controlling macrophage survival and efferocytosis M Piollet, F Porsch, G Rizzo, F Kapser, DJJ Schulz, MG Kiss, ... BioRxiv, 2023.05. 15.539977, 2023 | 9 | 2023 |
| Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit site–derived extracellular vesicles from myocardial infarction patients AS Ondracek, T Afonyushkin, A Aszlan, S Taqi, T Koller, T Artner, ... European Heart Journal, ehae584, 2024 | 1 | 2024 |
| Role of Antibodies and Their Specificities in Atherosclerotic Cardiovascular Disease J Deroissart, CJ Binder, F Porsch Arteriosclerosis, Thrombosis, and Vascular Biology 44 (10), 2154-2168, 2024 | | 2024 |
| Comprehensive failure of intracellular protein homeostasis kills myeloma and solid cancer cells following VCP/p97 inhibition K Parzych, S Loaiza, TM Chinn, P May, F Porsch, A Karadimitris, ... Cancer Research 75 (15_Supplement), 1261-1261, 2015 | | 2015 |
